Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Oct;67(10):4851-4865.
doi: 10.1007/s10620-022-07530-8. Epub 2022 May 27.

Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy

Anand Kumar  1   2 , Vinayak Shenoy  3   4 , Megan C Buckley  3   4 , Laura Durbin  3   4 , James Mackey  3   4 , Anjali Mone  3   4 , Arun Swaminath  3   4   5
Affiliations

Endoscopic Disease Activity and Biologic Therapy Are Independent Predictors of Suboptimal Bowel Preparation in Patients with Inflammatory Bowel Disease Undergoing Colonoscopy

Anand Kumar et al. Dig Dis Sci. 2022 Oct.

Abstract

Background and aims: Optimal bowel preparation (BP) is critical for endoscopic assessment of inflammation and dysplasia in patients with inflammatory bowel disease (IBD). Comorbidities and patient-related factors have been associated with suboptimal BP (SOBP) in the general population. We sought to identify disease-specific characteristics that may impact the quality of BP in patients with IBD.

Methods: We conducted a retrospective analysis of adult IBD patients who underwent outpatient colonoscopies between January 2014 and September 2020 at a large academic medical center. Quality of BP was documented using the Boston Bowel Preparation Scale (BBPS) or the Aronchick scale and dichotomized into "suboptimal" (BBPS 0-5 or Aronchick "fair," "poor," unsatisfactory") and "optimal" (BBPS 6-9 or Aronchick "excellent," "good"). IBD-specific and other factors associated with SOBP were evaluated using logistic regression analyses.

Results: Among a total of 395 IBD patients [54% males, mean age 40 years, 63% with Crohn's disease (CD), 35% with ulcerative colitis (UC)], 24.8% had SOBP. On multivariable analysis, moderate-to-severe endoscopic disease vs mild or inactive disease was associated with a higher odds of SOBP [adjusted OR 2.7(95% CI 1.52-4.94)], whereas baseline biologic use was associated with a lower odds of SOBP [aOR 0.24(0.09-0.65)] among the overall IBD cohort. Additionally, age > 65 years [aOR 2.99(1.19-7.54)] and single-dose vs split-dose BP [aOR 2.37(1.43-3.95)] were predictors of SOBP. In the subgroup analysis by IBD type, moderate-to-severe endoscopic disease predicted SOBP among both CD and UC cohorts.

Conclusion: Endoscopic disease activity was predictive of SOBP, and biologic therapy was protective against SOBP among IBD patients.

Keywords: Biologic therapy; Bowel preparation quality; Colonoscopy; Disease activity; Inflammatory bowel disease.

PubMed Disclaimer

Comment in

References

    1. Cellier C, Sahmoud T, Froguel E et al. Correlations between clinical activity, endoscopic severity, and biological parameters in colonic or ileocolonic Crohn’s disease. A prospective multicentre study of 121 cases. The Groupe d’Etudes Therapeutiques des Affections Inflammatoires Digestives. Gut. 1994;35:231–235. - PubMed - PMC
    1. O’Connor A, Ford AC. Poor Correlation Between Patient-reported and Endoscopic Components of the Mayo Score in Ulcerative Colitis. Gastroenterology. 2016;150:1037–1039. - PubMed
    1. American Society for Gastrointestinal Endoscopy Standards of Practice C, Shergill AK, Lightdale JR et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81:1101–1121.
    1. Nett A, Velayos F, McQuaid K. Quality bowel preparation for surveillance colonoscopy in patients with inflammatory bowel disease is a must. Gastrointest Endosc Clin N Am. 2014;24:379–392. - PubMed
    1. Rex DK, Schoenfeld PS, Cohen J et al. Quality indicators for colonoscopy. Am J Gastroenterol. 2015;110:72–90. - PubMed

Substances

LinkOut - more resources